KDM3A Polyclonal Antibody

KDM3A Polyclonal Antibody

The KDM3A Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of KDM3A protein expression in various biological samples. This antibody is produced using advanced recombinant DNA technology, ensuring high purity and quality.

KDM3A, also known as JHDM2A or JMJD1A, is a histone demethylase enzyme that plays a crucial role in epigenetic regulation. It is involved in the removal of methyl groups from histone H3 lysine 9 (H3K9), leading to gene activation and transcriptional regulation. Dysregulation of KDM3A has been implicated in various diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions.

The KDM3A Polyclonal Antibody has been extensively validated for its specificity and sensitivity in various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other related proteins, ensuring accurate and reliable results.

This antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size of 100 µg, allowing for multiple experiments. The KDM3A Polyclonal Antibody is suitable for use in both research and clinical settings, enabling scientists and clinicians to investigate the role of KDM3A in disease pathogenesis and therapeutic interventions.

To ensure optimal performance, it is recommended to follow the provided protocols and guidelines for sample preparation, antibody dilution, and detection methods. Storage at -20°C is advised to maintain the stability and integrity of the antibody.

In summary, the KDM3A Polyclonal Antibody is a reliable and efficient tool for the detection and analysis of KDM3A protein expression. Its high specificity, sensitivity, and ease of use make it an invaluable asset for researchers and clinicians studying the role of KDM3A in various biological processes and diseases.